World Stroke Congress 2025 – oral presentation

We are proud to announce that Lys Therapeutics will be participating and presenting at the 17th World Stroke Congress (#WSC2025), organized by the World Stroke Organization, taking place 22–24 October 2025 in Barcelona, Spain.

We will share groundbreaking results on our lead antibody LYS241, a humanized monoclonal antibody neutralizing tPA-induced excitotoxicity and blood-brain barrier disruption in ischemic stroke.

📅 Date: Friday, 24 October 2025
🕘 Session time: 10:00 – 11:30
🎤 Presenter: Dr. Manuel Blanc (France)
🕚 Lecture time: 11:06 – 11:17
🏛️ Room: 113

LYS241 selectively blocks the pathological tPA–NMDAr interaction while preserving normal NMDA receptor function. Our data demonstrate robust efficacy across both early and extended therapeutic windows, confirming its potential as a standalone therapy or in combination with thrombolysis and/or thrombectomy.

✨ A major step forward in redefining stroke treatment.

#WSC2025 #Stroke #StrokeInnovation #Neuroscience #Innovation #LysTherapeutics #LYS241 #tPA #NMDAr #Cytoprotection #Cerebroprotection #Neuroprotection #BBB